Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus

Arthritis & Rheumatism

Volumn 36, Issue 4, 1993, Pages 528-533

  May, Kimberly P ^a,b,c,d   West, Sterling G ^a,b,c,d   Moulds, Joann ^a,b,c,d   Kotzin, Brian L ^a,b,c,d  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C4; HLA ANTIGEN CLASS 2;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; HEREDITY; HLA TYPING; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; FAMILY HEALTH; FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PEDIGREE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027462219     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780360413     Document Type: Article

References (21)

1. Antiphospholipid antibody syndrome: immunological and clinical aspects
2. Acquired inhibitors of blood coagulation
3. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants‐I (ISLA‐I)
4. The Second International Anti‐Cardiolipin Standardization Workshop/The Kingston Anti‐Phospholipid Antibody Study (KAPS) Group
5. A solid phase enzyme immunoassay (ELISA) for the detection and quantitation of anticardiolipin antibody
6. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test
7. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times
8. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non‐SLE disorders
9. Familial association of the lupus anticoagulant
10. Familial occurrence of the antiphospholipid syndrome
11. Different clinical manifestations of a lupus anticoagulant in the same family
12. Lupus anticoagulant: a familial observation
13. Familial lupus anticoagulants
14. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986
15. Statement on the nomenclature of the human C4 allotypes
16. A novel immunoassay for the quantitation of human C4 gene products
17. Molecular heterogeneity of complement component C4‐null and 21‐hydroxylase genes in systemic lupus erythematosus
18. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant
19. HLA–DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus
20. HLA–DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients
21. The onset of disease in twins and siblings with systemic lupus erythematosus